Particulate matter pollution and the COVID-19 outbreak: results from Italian regions and provinces

被引:59
作者
Bianconi, Vanessa [1 ]
Bronzo, Paola [1 ]
Banach, Maciej [2 ,3 ]
Sahebkar, Amirhossein [4 ,5 ]
Mannarino, Massimo R. [1 ]
Pirro, Matteo [1 ]
机构
[1] Univ Perugia, Dept Med, Unit Internal Med, Perugia, Italy
[2] Med Univ Lodz, WAM Univ Hosp, Dept Hypertens, Lodz, Poland
[3] Polish Mothers Mem Hosp Res Inst PMMHRI, Lodz, Poland
[4] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Razavi Khorasan, Iran
[5] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Razavi Khorasan, Iran
关键词
deaths; incidence; PM2.5; PM10; SARS-CoV-2; AMBIENT FINE PARTICLES; AIR-POLLUTION; EXPOSURE; IMPACT; CHINA;
D O I
10.5114/aoms.2020.95336
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Particulate matter exposure has been associated with the appearance and severity of several diseases, including viral infections. The aim of this study was to investigate whether coronavirus disease 2019 (COVID-19) cases and deaths across Italian regions and provinces in March 2020 were linked to past exposure to fine and coarse particulate matter (namely, PM2.5 and PM10, respectively). Material and methods: Geographical distributions of COVID-19 cases and deaths (105,792 and 12,428, respectively, up to 31st March 2020), PM2.5 and PM10 exposure, and demographic characteristics were extracted from publicly accessible databases. Adjusted regression models were performed to test the association between particulate matter exposure in different Italian regions and provinces and COVID-19 incidence proportions and death rates. Results: A heterogeneous distribution of COVID-19 cases/deaths and particulate matter exposure was observed in Italy, with the highest numbers in Northern Italy regions and provinces. Independent associations between regional PM2.5/PM10 exposure and COVID-19 incidence proportion and death rate were observed (COVID-19 incidence proportion: beta = 0.71, p = 0.003, beta = 0.61, p = 0.031, respectively; COVID-19 death rate: beta = 0.68, p = 0.004 and beta = 0.61, p = 0.029, respectively). Similarly, PM2.5/PM10 exposures were independently associated with COVID-19 incidence proportion (beta = 0.26, p = 0.024 and (beta = 0.27, p = 0.006, respectively) at the provincial level. The number of days exceeding the provincial limit value of exposure to PM10 (50 mu g/m(3)) was also independently associated with the COVID-19 incidence proportion (beta = 0.30, p = 0.008). Conclusions: Exposure to PM2.5 and PM10 is associated with COVID-19 cases and deaths, suggesting that particulate matter pollution may play a role in the COVID-19 outbreak and explain the heterogeneous distribution of COVID-19 in Italian regions and provinces.
引用
收藏
页码:985 / 992
页数:8
相关论文
共 32 条
[11]   The impact of ambient fine particles on influenza transmission and the modification effects of temperature in China: A multi-city study [J].
Chen, Gongbo ;
Zhang, Wenyi ;
Li, Shanshan ;
Zhang, Yongming ;
Williams, Gail ;
Huxley, Rachel ;
Ren, Hongyan ;
Cao, Wei ;
Guo, Yuming .
ENVIRONMENT INTERNATIONAL, 2017, 98 :82-88
[12]  
Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1295, 10.1136/bmj.m1091]
[13]   Air pollution and respiratory viral infection [J].
Ciencewicki, Jonathan ;
Jaspers, Ilona .
INHALATION TOXICOLOGY, 2007, 19 (14) :1135-1146
[14]   Can atmospheric pollution be considered a co-factor in extremely high level of SARS-CoV-2 lethality in Northern Italy? [J].
Conticini, Edoardo ;
Frediani, Bruno ;
Caro, Dario .
ENVIRONMENTAL POLLUTION, 2020, 261
[15]   Air pollution and case fatality of SARS in the People's Republic of China: an ecologic study [J].
Yan Cui ;
Zuo-Feng Zhang ;
John Froines ;
Jinkou Zhao ;
Hua Wang ;
Shun-Zhang Yu ;
Roger Detels .
Environmental Health, 2 (1)
[16]  
Dossier di Legambiente, 2020, DOSSIER LEGAMBIENTE
[17]   Assessment of inflammatory markers, disease severity and comorbidities in very elderly patients with acute respiratory diseases [J].
Hazar, Armagan ;
Gundogus, Baran .
ARCHIVES OF MEDICAL SCIENCE, 2025, 21 (02) :451-462
[18]  
Horne BD, 2018, AM J RESP CRIT CARE, V198, P759, DOI [10.1164/rccm.201709-1883OC, 10.1164/rccm.201709-1883oc]
[19]  
Kan HD, 2005, BIOMED ENVIRON SCI, V18, P1
[20]   Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic [J].
Katsiki, Niki ;
Banach, Maciej ;
Mikhailidis, Dimitri P. .
ARCHIVES OF MEDICAL SCIENCE, 2020, 16 (03) :485-489